FORWARD FEATURES CALENDAR

Deals & Transactions

Mouro Capital leads Vesttoo’s USD15m Series B round

Vesttoo, a global Alternative Reinsurance and Investment platform, has secured a USD15 million Series B equity investment from Mouro Capital, which is backed by a large multinational bank, and MS&AD Ventures, the corporate venture capital fund of Japan-based MS&AD Insurance Group Holdings, the fifth largest insurance conglomerate in the world.

MarkLogic acquires SmartLogic

MarkLogic Corporation, a specialist in complex data integration and a portfolio company of Vector Capital, has acquired Smartlogic, a metadata management solutions provider and specialist in semantic AI technology.  As part of the transaction, Smartlogic’s founder and Chief Executive Officer, Jeremy Bentley, as well as other members of the senior

Luma Health raises USD130m in Series C funding

Luma Health, a patient engagement platform, has raised USD130 million in a Series C funding round led by FTV Capital, a sector-focused growth equity investment firm, with participation from existing investors.  This latest round brings Luma Health’s total funding raised to USD160 million.  The announcement follows 2x growth year over

Arlington Capital Partners portfolio company BlueHalo acquires Asymmetrik

Arlington Capital Partners (Arlington) portfolio company, BlueHalo, a provider of advanced engineering solutions and technology to the national security community, has acquired Asymmetrik. Founded in 2008, Asymmetrik is a leading developer of software solutions and technology tools used to enable the Intelligence Community’s (IC) most advanced programs. With a strong

Apollo Funds to acquire 50 per cent stake in Broad Reach Power from EnCap

Funds managed by Apollo affiliates have agreed to acquire a 50 per cent stake in Broad Reach Power LLC (Broad Reach), a leading utility-scale energy storage and renewable energy platform in the US.  The Apollo Funds will acquire the stake from existing investor EnCap Investments LP (EnCap) and its co-investment

LoQus23 Therapeutics exits stealth with GBP11.5m seed financing from the Dementia Discovery Fund and Novartis Venture Fund

LoQus23 Therapeutics (LoQus23), a company discovering small molecule therapies that target aberrant DNA mismatch repair (MMR) to treat Huntington’s and other triplet repeat diseases (TRDs), has closed its GBP7 million extended seed round.  LoQus23 secured the financing from Novartis Venture Fund (NVF) and its founding investor the Dementia Discovery Fund

DWS fund to acquire radiotherapy provider RON

DWS has acquired RadioOnkologieNetzwerk GmbH (RON), the leading radiotherapy platform provider in Germany, on behalf of its third Pan-European Infrastructure (PEIF III) fund, in partnership with the founders, Dr Sandra Röddiger and Dr Ralf Kurek. RON has a strong track record of providing high quality cancer care services to its

TDC makes first Integrated Finance investment in MCG Group

The MCG Group has secured a GBP20 million funding package from Tosca Debt Capital LLP (TDC) to support its ambitious growth plans. The MCG Group was recently named as one of ‘The UK’s 100 Best Mid-Sized Companies to Work For’ as well as one of ‘Recruitment’s 40 Best Companies to

Events

12 November, 2026 – 5:00 pm

Directory Listings